EUCTR2015-003064-36-AT进行中（未招募）不适用
Impact of selective alpha 1A receptor antagonists on the pupil size after instillation of tropicamide 0.5% and phenylephrine 10% - DEF
Vienna Institute for Research in Ocular Surgery0 个研究点开始时间: 2015年7月24日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Inclusion criteria for the study group
- •-Age 21 and older
- •-Age-related cataract
- •-therapy with systemic selective alpha 1A antagonists (tamsulosin)
- •-written informed consent to participation in the study
- •Inclusion criteria for the control group
- •-Age 21 and older
- •-Age-related cataract
- •-written informed consent to participation in the study
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 50
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Exclusion criteria for the study group
- •-Pregnancy (pregnancy test will be taken pre-operatively in women of reproductive age)
- •-Traumatic cataract
- •-Any ophthalmic pathology that could compromise the measurements
- •Exclusion criteria for the control group
- •-Pregnancy (pregnancy test will be taken pre-operatively in women of reproductive age)
- •-Traumatic cataract
- •-Any ophthalmic pathology that could compromise the measurements
- •-Current or previous therapy with systemic alpha 1A antagonists
研究者
相似试验
进行中（未招募）
不适用
Effect of selective alpha 1A receptor antagonists on the iris dilator muscleEffect of selective alpha 1A receptor antagonists on the iris dilator muscleEUCTR2015-003061-28-ATVienna Institute for Research in Ocular Surgery
尚未招募
不适用
The effects of selective alpha-1-adrenergic receptor antagonists in patients with lower urinary tract symptoms caused by benign prostatic hyperplasiawho failed to obtain sufficient efficacy by previous alpha-1-blockades. . A comparison of Naftopidil or Silodosin.Benign Prostatic HyperplasiaJPRN-UMIN000003609Kansai Medical University Takii Hospital100
进行中（未招募）
不适用
Study to investigate the effect of the A1 agonist capadenoson on ventricular HR in patients with persistent or permanent atrial fibrillation by administration of capadenoson in a dose of 4 mg once daily for five daysMedDRA version: 9.1Level: LLTClassification code 10016566Term: Fibrillation atrialAtrial fibrillationEUCTR2007-003619-30-DEBayer HealthCare AG
招募中
2 期
Doxazosin to Prevent Severe COVID-19 (CALM-COVID Trial)CTRI/2021/09/036099Johns Hopkins University School of Medicine
已完成
不适用
Compare efficacy and safety of alpha1-blockers in patients with benign prostatic hyperplasiaBenign Prostatic HyperplasiaJPRN-UMIN000010198Matsushita Urologocal Clinic70